Biomerieux S A Unsp/Adr (BMXXY) Q2 2024 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good day and welcome to the H1 2024 results conference call. Today's conference is being recorded. At this time, I'd like to turn the conference over to Mr. Emre Kfece. Please go ahead. Thank you, Jennifer. Good afternoon, everyone, and thank you for joining us to review the BioMérieux for this H1 2024 Finance Performance Review. I'm online with Pierre Boulud, CEO, together with Guillaume Bourg, CFO. Before handing the call over to Pierre for preliminary remarks, please note that this conference call will include forward-looking statements that may change or be modified due to uncertainties and risks related to the company's environment. Accordingly, we cannot give any assurances as to whether we will achieve these objectives. I also remind you that today's call is being recorded and that the replay will be available on our website, www.biomérieux-finance.com. I'll now end the call over to Pierre, and then we will open the call to discussion and questions. Pierre? Thank you, Aymeric. Good morning, good afternoon, everybody. So a word on the agenda for today. I'll start by sharing with you a quick reminder on our Go28 plan. Then we'll go through the business highlights for the first half of the year. I'll hand over to Guillaume, who will share with you the details of the financial performance. And I'll close the first part of the call on the business outlook, the perspective for the full year 2024, so that we can open for Q&A. Aymeric has already shared the disclaimer on forward-looking statements, so if we move directly to the Go28 strategic plan that we shared with you on April 9th, a quick reminder on the four pillars that we shared with you. First pillar relates to going for growth, so the sales growth ambition that we have for the next five years. The second dime...